Live Quote · NYSEEVMNHealthcare· Biotechnology

Evommune, Inc.

$7.04▼ 2.76%($-0.20)
MKT CAP $291.10MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
52/100
▌ Mixed
73
Valuation
20
Profitability
55
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EVMN research report →

Analyst Price Target
$25.00+255.1% vs. today

Range $8 – $50

Analyst RatingBuy
3 Buy2 Hold0 Sell

Price Chart

-62.37% · this period
$31.57$18.34$5.10Nov 20May 26Nov 20
52-Week Range7% of range
Low
$4.94
Current
$7.04
High
$33.20